Back
Biomarin Pharmaceutical Stock Price Chart
Sponsored
BMRN
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
BMRN
Biomarin Pharmaceutical
Last Price:
71.43
Seasonality Move:
5.7%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
Biomarin Pharmaceutical Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 79.35 | Sell |
20-day SMA: | 85.57 | Sell |
50-day SMA: | 85.93 | Sell |
200-day SMA: | 87.02 | Sell |
8-day EMA: | 77.71 | Sell |
20-day EMA: | 82.86 | Sell |
50-day EMA: | 84.86 | Sell |
200-day EMA: | 86.16 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.61 | Sell |
Relative Strength Index (14 RSI): | 22.64 | Sell |
Chaikin Money Flow: | 871265 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.02 - 93.28) | Sell |
Bollinger Bands (100): | (78.57 - 88.29) | Sell |
Biomarin Pharmaceutical Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 71.14 while BMRN 8-day simple moving average is 79.35, which is a Sell signal.
- The stock price of BMRN is 71.14 while Biomarin Pharmaceutical 20-day SMA is 85.57, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 85.93 while BMRN share price is 71.14, making it a Sell technically.
- BMRN stock price is 71.14 and Biomarin Pharmaceutical 200-day simple moving average is 87.02, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Sell
The current Biomarin Pharmaceutical [BMRN] share price is $71.14. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
13.54B
Price in USD:
71.14
Share Volume:
2.17M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
68.83
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 71.14 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 71.14 while BMRN 8-day exponential moving average is 77.71, which is a Sell signal.
- The stock price of BMRN is 71.14 while Biomarin Pharmaceutical 20-day EMA is 82.86, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 84.86 while BMRN share price is 71.14, making it a Sell technically.
- BMRN stock price is 71.14 and Biomarin Pharmaceutical 200-day simple moving average is 86.16, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -3.61, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 22.64, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (80.02 - 93.28), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (78.57 - 88.29), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.